Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – Time to Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s stock price gapped up before the market opened on Tuesday. The stock had previously closed at $6.60, but opened at $6.95. Coloplast A/S shares last traded at $6.88, with a volume of 3,927 shares trading hands.

Coloplast A/S Stock Performance

The stock has a market capitalization of $15.46 billion, a PE ratio of 36.12, a P/E/G ratio of 2.35 and a beta of 0.21. The company has a debt-to-equity ratio of 1.51, a quick ratio of 0.94 and a current ratio of 1.56. The firm has a 50 day moving average of $6.72 and a 200-day moving average of $6.45.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share for the quarter, meeting the consensus estimate of $0.10. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%. The company had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Research analysts forecast that Coloplast A/S Sponsored ADR will post 0.40 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.

The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management.

Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy.